European Health Technology Assessment

Strategy

• Continuous monitoring of European assessments
• Support in the planning of studies
• Lifecycle strategy (post launch evidence generation; PLEG)
• Cooperation with European partner agencies
• Support in the coordination of the strategy of individual countries as well as in the development of the overall strategy

Joint Clinical Assessment (JCA)

• Support in the scoping process
• Medical Writing of the European dossier
• Parallel coordination and preparation of the German dossier
• Processing of study results and re-evaluation of studies according to EUnetHTA requirements
• Calculation of indirect comparisons, (IPD-) meta-analyses and sensitivity analyses
• Review of the JCA report ("fact check")

Joint Scientific Consultations (JSC)

• Support for JSC and parallel EMA/EUnetHTA JSC
• Support for national consultations of the European countries
• Preparation of documents, training, Q&A
• Follow-up of the JSC, derivation of implications for national HTAs of the European countries and EU HTA

Workshops

• Organizational readiness
• Feasibility analysis
• Pipeline check and mock-up
   

European Partner Network

Ecker + Ecker maintains an extensive European partner network where 14 experienced consulting firms are in a regular exchange on EU-HTA. Ecker + Ecker is therefore also a central contact for the different national perspectives regarding market access and EU-HTA. The partner network provides access to 27 European countries.